Sample | Formation in mice | Latency to palpable tumor formation | Passage in Mice | Metastasis | Metastatic Latency | Age | Diagnosis | Grade | ER/PR/Her2 Status |
---|---|---|---|---|---|---|---|---|---|
4 | 0/2 | N/A | N/A | Not Determined | N/A | 56 years | IDC | Grade 2 | ER+/PR+/Her2- |
5 | 5/6 | 74 days | Yes | Yes | 254 days | 44 years | IDC | Grade 3 | ER+/PR+/Her2- |
6 | 6/6 | 47 days | Yes | Yes | 232 days | 62 years | IDC with lymphovascular invasion | Grade 2 | ER+/PR+/Her2+ |
7 | 5/6 | 72 days | Yes | Yes | 214 days | 77 years | IDC | Grade 2 | ER-/PR-/Her2- |
8 | 4/6 | 35 days | Yes | Yes | 248 days | 63 years | IDC | Grade 2 | ER+/PR+/Her2- |
9 | 6/6 | 46 days | Yes | Yes | 279 days | 66 years | IDC | Grade 1 | ER+/PR+/Her2 |